Oarsman Capital’s Axcelis ACLS Stock Holding History

Oarsman Capital’s Portfolio ACLS Stock Details ACLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-170	Closed	-$11.9K	–	241
2024 Q4	$11.9K	Buy	170 +10	+6%	+$830	﹤0.01%	672
2024 Q3	$16.8K	Buy	+160	New	+$18.7K	﹤0.01%	626

Other funds holding ACLS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Reinhart Partners Mequon, Wisconsin $4.11B AUM 38.38% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

Oarsman Capital's ACLS Position: Q1 2025 in Review

Oarsman Capital sold out of Axcelis (ACLS) in Q1 2025, closing a stake of 170 shares — an estimated $11.9K sold.

Oarsman Capital first reported a position in ACLS in Q3 2024 and held it in 2 quarters. The position peaked at $16.8K in Q3 2024. 307 funds tracked by Wall St. Rank hold ACLS as of Q1 2025.

Oarsman Capital reported no remaining Axcelis position as of Q1 2025 after selling out during the quarter.
Oarsman Capital sold 170 Axcelis shares in Q1 2025, an estimated $11.9K.
Oarsman Capital first reported a position in Axcelis in Q3 2024 and held it in 2 quarters.
Oarsman Capital's Axcelis position peaked at $16.8K in Q3 2024.
307 funds tracked by Wall St. Rank held Axcelis as of Q1 2025.

Based on Oarsman Capital's 13F filing for Q1 2025, filed 14 May 2025.